Radium-223 dichloride (xofigo)
Ended Awarded Last action
- Contract number
- 36C25023N0117
- Awardee
-
Bayer Healthcare Pharmaceuticals Inc. UEI V1EVGCK7XES8 Part of Bayer Aktiengesellschaft
- Awarding agency
-
Veterans Integrated Service Network 10
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- -$223,133
Award facts
- Contract value
- $0.00 Current and potential, with all options
- Completion date 100% complete
-
- Current, with exercised options
- Potential, with all options
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Whippany, Hanover, NJ 07981, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$55,730 | |
| Funding Only Action | -$167,402 |
About this award
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 10 awarded a firm fixed price blanket purchase agreement call contract to Bayer Healthcare Pharmaceuticals Inc. for the pharmaceutical Radium-223 Dichloride (Xofigo) with a period of performance through September 30, 2023. The contract was awarded on October 1, 2022 under the Pharmaceuticals and Drugs Federal Supply Schedule, known as FSS-61-IB, with no set-aside designation specified. Bayer Healthcare Pharmaceuticals Inc. is a subsidiary of Bayer AG within the Pharmaceuticals division. The potential value of the contract is $0.00.
Quick answers
Who was awarded contract 36C25023N0117?
36C25023N0117 was awarded to Bayer Healthcare Pharmaceuticals Inc. by Veterans Integrated Service Network 10 (Veterans Health Administration) on October 1, 2022.
How much is contract 36C25023N0117 worth?
The government has obligated -$223,133 on 36C25023N0117.
Is contract 36C25023N0117 an order under another contract?
Yes. 36C25023N0117 is a BPA call under V797P2202D-36C25020A0024, a blanket purchase agreement, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C25023N0117 competed?
The extent of competition for 36C25023N0117 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award